You've just added:

Home / News

News + Media

February 08, 2023

Single Drug Injection Wards off COVID-19 Hospitalizations, in Stanford Medicine-Led Trial

In an international, multicenter, pivotal Phase 3 trial, a single under-the-skin injection of a biological drug given to patients within seven days of the onset of COVID-19 symptoms cut the likelihood they needed to be hospitalized in half. Continue Reading

January 27, 2023

Sol-Gel To Tackle Gorlin Syndrome In Pact With BridgeBio’s PellePharm

Sol-Gel Technologies, Ltd. announced today the acquisition of topically-applied patidegib, a hedgehog signaling pathway blocker, for the treatment of Gorlin syndrome from PellePharm, Inc. Continue Reading

January 24, 2023

New Oral Compound Developed by Mass General Researchers May Help Prevent and Treat Osteoporosis

A team led by investigators at Massachusetts General Hospital (MGH), including Marc Wein, MD, PhD, Massachusetts General Hospital, 2018 Harrington Scholar-Innovator, might lead to a new, more convenient drug for preventing and treating osteoporosis. Continue Reading

January 12, 2023

Alzheimer’s Drug Discovery Foundation and Harrington Discovery Institute to Support Promising Research to Protect the Alzheimer’s Brain

Dr. Christiane Wrann of Massachusetts General Hospital selected for research aimed at using the novel exercise hormone irisin to treat Alzheimer’s disease Continue Reading

November 22, 2022

ASU Researchers Developing Pioneering Drug to Treat Alzheimer's Disease in Down Syndrome Patients

Travis Dunckley, PhD, University of Arizona, 2016 ADDF-Harrington Scholar and team have developed a candidate drug they hope may successfully block the development or advancement of Alzheimer’s disease in Down syndrome patients. Continue Reading

November 17, 2022

Cleveland Researchers Discover New Oral Drug for Lowering Cholesterol

Study led by University Hospitals and Case Western Reserve University team details a small-molecule drug that lowers cholesterol by 70% in animal models Continue Reading

October 19, 2022

PIC Closes $35M Series A to Advance Novel Breast Cancer Therapeutic

PIC Therapeutics has closed a $35 million Series A financing round centered around the advancement of its lead asset, a novel therapeutic for advanced metastatic breast cancer. Continue Reading

October 19, 2022

Harrington Discovery Institute at University Hospitals and Case Western Reserve School of Medicine Open Call for 2023 Harrington-MSTP Scholar Award

Grant award provides MD/PhD candidates with funding and expertise to translate promising scientific discoveries into medicines Continue Reading

August 18, 2022

Harrington Scholar Developing a Universal Therapeutic that can Prevent and Treat All Strains of Influenza A

Harrington Scholar developing a universal treatment to prevent and treat influenza A. Continue Reading

August 15, 2022

Novel Oral SIK Inhibitors for Musculoskeletal Diseases Licensed to Radius Health

Licensing IP for SIK Inhibitors to Radius Health Continue Reading